Literature DB >> 3094629

Clearance of psoriasis with low dose cyclosporin.

C E Griffiths, A V Powles, J N Leonard, L Fry, B S Baker, H Valdimarsson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3094629      PMCID： PMC1341449          DOI： 10.1136/bmj.293.6549.731

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  2 in total

1.  Epidermal T lymphocytes and HLA-DR expression in psoriasis.

Authors:  B S Baker; A F Swain; L Fry; H Valdimarsson
Journal:  Br J Dermatol       Date:  1984-05       Impact factor: 9.302

2.  T-cell subpopulations in the blood and skin of patients with psoriasis.

Authors:  B S Baker; A F Swain; H Valdimarsson; L Fry
Journal:  Br J Dermatol       Date:  1984-01       Impact factor: 9.302
  2 in total
  30 in total

1.  Reduced IFN-gamma responses associated with HLA-DR15 presentation of streptococcal cell wall proteins to dermal Th-1 cells in psoriasis.

Authors:  Barbara S Baker; Jean-Marc Ovigne; Vincent A Fischetti; Anne Powles; Lionel Fry
Journal:  J Clin Immunol       Date:  2003-09       Impact factor: 8.317

2.  HLA-G and NK receptor are expressed in psoriatic skin: a possible pathway for regulating infiltrating T cells?

Authors:  S Aractingi; N Briand; C Le Danff; M Viguier; H Bachelez; L Michel; L Dubertret; E D Carosella
Journal:  Am J Pathol       Date:  2001-07       Impact factor: 4.307

3.  Differential expression of cyclophilin isoforms during keratinocyte differentiation.

Authors:  D Chatellard-Gruaz; J H Saurat; G Siegenthaler
Journal:  Biochem J       Date:  1994-11-01       Impact factor: 3.857

4.  Influence of systemic cyclosporin A on interleukin-2 and epidermal growth factor receptor expression in psoriatic skin lesions.

Authors:  A Horroccks; A D Ormerod; J I Duncan; A W Thomson
Journal:  Clin Exp Immunol       Date:  1989-11       Impact factor: 4.330

5.  Clearance of severe psoriasis after allogenic bone marrow transplantation.

Authors:  D J Eedy; D Burrows; J M Bridges; F G Jones
Journal:  BMJ       Date:  1990-04-07

6.  Immunohistochemical analysis of contact sensitivity reactions in the guinea-pig using novel monoclonal antibodies: the influence of topical cyclosporin A.

Authors:  S N Payne; A W Thomson
Journal:  Clin Exp Immunol       Date:  1989-03       Impact factor: 4.330

7.  Lack of effect of spiramycin on cyclosporin pharmacokinetics.

Authors:  L Vernillet; P Bertault-Peres; Y Berland; J Barradas; A Durand; M Olmer
Journal:  Br J Clin Pharmacol       Date:  1989-06       Impact factor: 4.335

8.  Chinese herbal medicine (Tuhuai extract) exhibits topical anti-proliferative and anti-inflammatory activity in murine disease models.

Authors:  Mao-Qiang Man; Yuejun Shi; Mona Man; Seung Hun Lee; Marianne Demerjian; Sandra Chang; Kenneth R Feingold; Peter M Elias
Journal:  Exp Dermatol       Date:  2008-03-13       Impact factor: 3.960

Review 9.  Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.

Authors:  Diana Faulds; Karen L Goa; Paul Benfield
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

Review 10.  Immunopathogenic mechanisms in psoriasis.

Authors:  J E Gudjonsson; A Johnston; H Sigmundsdottir; H Valdimarsson
Journal:  Clin Exp Immunol       Date:  2004-01       Impact factor: 4.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.